Urinary angiotensin converting enzyme 2 is strongly related to urinary nephrin in type 2 diabetes patients

Angiotensin converting enzyme 2 and the kidney

(2016) David I. Ortiz-Melo et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice

(2016) Lai-Jiang Chen et al.   PEPTIDES

Relationship of adiponectin to markers of oxidative stress in type 2 diabetic patients: influence of incipient diabetes-associated kidney disease

(2015) Cosmina Ioana Bondor et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Urinary Angiotensin Converting Enzyme 2 Increases in Patients With Type 2 Diabetic Mellitus

(2015) Yaoxian Liang et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker

(2014) M. Furuhashi et al.   AMERICAN JOURNAL OF HYPERTENSION

Urinary angiotensin-converting enzyme 2 increases in diabetic nephropathy by angiotensin II type 1 receptor blocker olmesartan

(2014) Masanori Abe et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Proximal Tubule Dysfunction Is Associated with Podocyte Damage Biomarkers Nephrin and Vascular Endothelial Growth Factor in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study

(2014) Ligia Petrica et al.   PLoS One

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects

(2013) Manuel Haschke et al.   CLINICAL PHARMACOKINETICS

Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathy

(2013) Jonathan Fraportti do Nascimento et al.   BMC Nephrology

High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria

(2012) Se Eun Park et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

(2012) Renisha Nadarajah et al.   KIDNEY INTERNATIONAL

Dysregulated Nephrin in Diabetic Nephropathy of Type 2 Diabetes: A Cross Sectional Study

(2012) Belinda Jim et al.   PLoS One

Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition

(2011) L. M. Burrell et al.   EXPERIMENTAL PHYSIOLOGY

Urinary angiotensin-converting enzyme 2 in patients with CKD

(2011) SONOO MIZUIRI et al.   NEPHROLOGY

Long-term systemic angiotensin II type 1 receptor blockade regulates mRNA expression of dorsomedial medulla renin-angiotensin system components

(2011) Shea Gilliam-Davis et al.   PHYSIOLOGICAL GENOMICS

Prevention of Angiotensin II–Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2

(2010) JiuChang Zhong et al.   HYPERTENSION

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

(2009) G. Y. Oudit et al.   DIABETES

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

(2008) Heather N. Reich et al.   KIDNEY INTERNATIONAL